Clinical Trial Update: A Phase 1b Study of Paclitaxel And Ricolinostat For The Treatment Of Gynecological Cancer [Phase 1]

View source ↗

Summary

Phase 1b study of paclitaxel with ricolinostat for gynecologic cancer was terminated; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Ricolinostat (ricolinostat)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 1 | Status: TERMINATED | Results posted: 2019-11-08